Brain47Brain47Join Brain47
0QYJ

Salesforce, Inc.

Common Stock · USD · NYSE

CRMT212

Price

$177.215

-1.27%

Cap

—

Earnings

—

30d Trend

-1.6%

0QYJ
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

17% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level30
Momentum47
Technical57
Fund Quality55
Cost Efficiency68

Raw weighted: 59×Macro 0.99 (−1%)=58

RISK

30/100
90d Volatility
16.7%Low
ATR %
1.3%Low daily moves
Max Drawdown (1Y)
-11.9%Resilient

MOMENTUM

47/100
12-1M Momentum
-4.1%Downtrend
6-1M Momentum
-1.1%Flat
1M Return
+1.7%Stable
Relative Strength
-2.5% vs sectorIn-line

TECHNICAL

57/100
RSI (14)
51.3Neutral
Price vs SMA200
+1.0%Flat
MACD
+0.17Bullish momentum
Bollinger Band
57%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.161Noisy/choppy

FUND QUALITY

55/100
Replication
PhysicalHolds actual assets
Holdings
29 positionsConcentrated
Domicile
FranceCheck tax treaty
Yield
0.00% (Accumulating)Growth-focused

COST EFFICIENCY

68/100
Expense Ratio
0.30%Low cost
Fund Size (AUM)
$241MSmall
Tracking Difference
-0.01%Excellent tracking

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months45
3-12 months46
1-5+ years ★60

12-24 month value thesis — fundamentally underpriced

BRAIN47'S ASSESSMENT

I rate Salesforce, Inc. at 58/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 70/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+1.7%

3 MONTHS

-7.7%

12 MONTHS

-2.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

12-24 month value thesis — fundamentally underpriced. low-risk profile and Cost Efficiency (68) are the primary strengths. Historical volatility is normal at 17%. I classify this as a defensive holding — low volatility and resilient fundamentals provide portfolio ballast.

defensiveScore: 58/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.